Cytokine zalpha11 ligand polynucleotides
USRE41129E1 · kind E1 · reissue
6Cited by
4References
142Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2006 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Feb 2, 2026 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.